Blog
Cancer diagnostics overview
Biopsies and Liquid Biopsies Imaging Technologies Personalized Medicine Overview and Impact This summary encapsulates the essence of the “Cancer diagnostics” section, illustrating the advancements in diagnostic methodologies that are central to the fight against cancer, underscoring the importance of precision and personalization in modern oncology.
Innovation response to cancer
Oncology Market Growth The global oncology market, which includes diagnostics and therapy, is expected to experience substantial growth over the next decade, with its value projected to increase from EUR 185.6 billion in 2022 to over EUR 429.3 billion by 2032. This growth, with a compound annual growth rate (CAGR) of 8.8%, is driven by […]
Digistain clinical validation study published In ‘Breast Cancer Research & Treatment’
A clinical validation study for Digistain’s novel, rapid, and cost-effective alternative to transcriptomic risk profiling in order to efficaciously predict disease-free survival has been published in the Springer Nature Journal of Breast Cancer Research & Treatment. The landmark independent clinical study, authored by some of the leading names in breast cancer oncology and pathology demonstrated that […]
Digistain – EIT Health Catapult 2023-2024 semi-finalist
We are delighted that our partner has been selected by EIT Health as a semi-finalist. It is wonderful to be recognised for their groundbreaking work in advancing breast cancer biomarker analytics.
Exploring the Global Trends of Breast Cancer in Women
Breast cancer is a global health issue affecting millions of women each year. Although mortality rates have declined in the last decade due to improved treatments and early detection, it remains one of the leading causes of death in women worldwide. Understanding the global trends of breast cancer can help inform public health policies and […]